42
Participants
Start Date
September 30, 2014
Primary Completion Date
November 30, 2014
Study Completion Date
November 30, 2014
Organophosphate
Chlorpyrifos 50% plus cypermethrin 5%, WHO Class II: Moderately hazardous
Placebo
Multineem, WHO Class U: Unlikely to present acute hazard in normal use
Augustinus Fonden
OTHER
Bispebjerg Hospital
OTHER